Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

AbbVie Receives Positive CHMP Opinion for MAVIRET in Acute Hepatitis C Treatment

Monday, May 25, 2026

AbbVie announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency has adopted a positive opinion recommending approval of MAVIRET for the treatment of acute hepatitis C virus HCV infection in adults and ch...

Gilead Sciences Receives Approval for Hepcludex as the Treatment for Chronic HDV

Monday, May 25, 2026

Gilead Sciences has announced that the US Food and Drug Administration FDA has granted accelerated approval to Hepcludex bulevirtidegmod mg for the treatment of adults living with chronic hepatitis delta virus HDV infection

Bristol Myers Squibb Enters into Agreement with Anthropic for AI Deployment Across Global Operations

Thursday, May 21, 2026

Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy Claude Enterprise across its global operations

Engage Bio Acquired by Lilly to Advance Non-Viral Genetic Medicines

Thursday, May 21, 2026

Engage Biologics has been acquired by Eli Lilly and Company to support the development of nonviral genetic medicines

Exelixis and Merck Collaborate on Phase 3 Trial for Colorectal Cancer Treatment

Wednesday, May 20, 2026

Exelixis has announced a clinical development collaboration with Merck for the Phase STELLAR pivotal trial in patients with colorectal cancer CRC

AstraZeneca and Daiichi Sankyo Expand ENHERTU Use in Early HER2-Positive Breast Cancer in the US

Tuesday, May 19, 2026

AstraZeneca and Daiichi Sankyo have received approval from the US Food and Drug Administration for the use of Enhertu trastuzumab deruxtecan in both neoadjuvant and adjuvant treatment settings for patients with HERpositive early breast cancer

Regeneron and Parabilis Partner to Develop Antibody-Helicon Conjugates Across Multiple Therapeutic Areas

Tuesday, May 19, 2026

Regeneron Pharmaceuticals has announced a strategic research collaboration with Parabilis Medicines to discover and develop therapeutic candidates using Parabilis Helicon peptide platform

Elabscience Launches PolyHRP-Streptavidin Conjugate for ELISA Testing

Thursday, May 14, 2026

Elabscience has launched a selfdeveloped PolyHRPStreptavidin conjugate designed to improve the sensitivity of enzymelinked immunosorbent assay ELISA testing for lowabundance biomarker detection

Erasca Enters into Collaboration with Merck to Evaluate ERAS-0015 with KEYTRUDA in RAS-Mutant Solid Tumours

Tuesday, May 12, 2026

Erasca has entered into a clinical trial collaboration and supply agreement with Merck to evaluate ERAS in combination with KEYTRUDA for patients with RASmutant solid tumours

Hengrui Pharma Enters into Collaboration with Bristol Myers Squibb to Advance Innovative Therapies

Tuesday, May 12, 2026

Hengrui Pharma and Bristol Myers Squibb have entered into global strategic collaboration and licensing agreements to develop a portfolio of earlystage programmes across oncology haematology and immunology